Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00359489 · ClinicalTrials.gov registry record
Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 30
- Enrollment target
NCT00359489: Completed study, sponsored by Pfizer.
NCT00359489 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00359489 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.
Interventions
- DEVICE cardiac echosonography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-04 |
| Est. Completion | 2007-07 |
What the finished NCT00359489 record still lists
NCT00359489 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which cardiac echosonography is the first listed.
NCT00359489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00359489 about?
NCT00359489 is a clinical study titled "Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.". Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.
What is the current status of trial NCT00359489?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2007-04. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00359489?
The interventions under investigation include: cardiac echosonography (DEVICE).
Who is sponsoring clinical trial NCT00359489?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia